TAK R&D to Revenue
Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) · R&D to Revenue
TAK R&D to Revenue
Latest reported15.00%period ending
TAK FY R&D/Revenue (0.00% → 15.00%)
Latest values, visible window
High-resolution chart · PNG
TAK r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 15.0015% | |
| 15.9384% | |
| 17.0886% | |
| 15.7251% | |
| 14.7404% | |
| 14.2524% | |
| 14.9517% | |
| 17.5593% | |
| 18.381% | |
| 17.9917% | |
| 19.136% | |
| 20.6849% | |
| 20.1905% | |
| 20.6338% | |
| 18.6811% | |
| 20.3521% | |
| 20.2182% | |
| 29.4504% | |
| 20.0602% | |
| 14.8104% | |
| 13.9947% | |
| 12.5964% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |